Sands Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Sands Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-380,307	Closed	-$43.4M	–	80
2021 Q2	$43.4M	Sell	380,307 -48,588	-11%	-$5.68M	0.07%	69
2021 Q1	$51.6M	Hold	428,895	–	–	0.1%	65
2020 Q4	$43.6M	Hold	428,895	–	–	0.08%	71
2020 Q3	$33.2M	Hold	428,895	–	–	0.07%	69
2020 Q2	$30.9M	Hold	428,895	–	–	0.07%	71
2020 Q1	$30.9M	Hold	428,895	–	–	0.1%	67
2019 Q4	$32.3M	Sell	428,895 -150,000	-26%	-$6.57M	0.09%	63
2019 Q3	$8.28M	Hold	578,895	–	–	0.03%	75
2019 Q2	$9.17M	Buy	+578,895	New	+$11.6M	0.03%	74

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Sands Capital Management's KRTX Position: Q3 2021 in Review

Sands Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2021, closing a stake of 380,307 shares — an estimated $43.4M sold.

Sands Capital Management first reported a position in KRTX in Q2 2019 and held it in 9 quarters. The position peaked at $51.6M in Q1 2021. 159 funds tracked by Wall St. Rank hold KRTX as of Q3 2021.

Sands Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Sands Capital Management sold 380,307 Karuna Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $43.4M.
Sands Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Sands Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $51.6M in Q1 2021.
159 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Sands Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.